An embattled industry is pushing back against complaints of high drug prices, constant drug advertising and companies that don't invest enough in research. Here's a Q&A with Stephen Ubl, CEO of the industry's trade group.
The West Lafayette-based biotech firm once was seen as a rising star with a pipeline that could save cancer patients. Now, 20 years after its founding, without a single launch, it is laying off 40 percent of its workforce.
The acquisition of the Premier Healthcare physician group and the groundbreaking of a $340 million hospital on the IU campus will give the Indianapolis-based health system a stronger foothold in Bloomington.